Skip to main content
Clinical Trials/NCT03690180
NCT03690180CompletedNot Applicable

Hypomagnesemia as a Marker of Diabeteiv Nephropathy

Fayoum University1 site in 1 country100 target enrollmentStarted: January 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
1
Primary Endpoint
Decrease in serum magnesium

Study Overview

Brief Summary

To find if there is a corrolatation between Microalbuminurea and diabetic retinopathy, in daibetic patients

Detailed Description

40 Daibetic patients with microalbuminurea will be subjeted to full clinical examination and fundus examination,20 control diabetics with out microalbuminurea will also be included for comparison,patients will be selected from the outpatient clinic 0f fayoum university hospital.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diabetics on oral treatment,diabetics on insulin

Exclusion Criteria

  • Healthy volunteers,,hypertensive patients with normal blood glucose

Outcomes

Primary Outcomes

Decrease in serum magnesium

Time Frame: One month

statistical significant change in serum magnesium in diabetics with microalbuminuria

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmed Abdelkawi Hammad

Lecturer of Medicine,Faculty of Medicine,Fayoum university

Fayoum University

Study Sites (1)

Loading locations...

Similar Trials

Hypomagnesemia and Diabetic Nephropathy | Clinical Trial